Brain Storm
Brain Storm, licence 80132011: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Immunegy Inc.
- NPN or DIN-HM
- 80132011
- Status
- Active licence
- Licence date
- 20 June 2024
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 160.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
| Piper nigrum Source : Piper nigrum - fruit | 5.0 mg | Not calculated |
| Bacopa monnieri Source : Bacopa monnieri - Sommité (herbe) Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 9 g Potency : 40.0 % Bacosides | 300.0 mg | Not calculated |
| L-théanine Source : Camellia sinensis - feuille | 50.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 60:1 Dry plant equivalent : 3600 mg Potency : 24.0 % Flavonoid glycosides | 60.0 mg | Not calculated |
Non-medicinal ingredients
Saveur de pêche, Extrait de Yerba Maté, Maltodextrine, bêta-Carotène, Saveur de limonade, Acide citrique, Sucralose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 9000.0 mg | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive/brain health/function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80132011
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.